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Abstract
Background: Lipomas are masses of mesenchymal origin, comprising of adipocytes, and are often clinically
unremarkable but can be alarming to owners. Although lipomas are reportedly common in dogs, no studies have
specifically investigated risk factors associated with their occurrence. This study was a large-scale retrospective
analysis of electronic patient records of dogs attending practices participating in VetCompass™. Univariable and
multivariable logistic regression methods were used to evaluate associations between risk factors and primary-care
veterinary diagnosis of lipoma.
Results: From 384,284 dogs under veterinary care during 2013 at 215 primary practice clinics in the UK, there were
2765 lipoma cases identified giving a one-year prevalence of 1.94% (95% CI: 1.87–2.01). Breeds with the highest
lipoma prevalence included Weimaraner (7.84%, 95% CI 6.46–9.40), Dobermann Pinscher (6.96%, 95% CI 5.67–8.44),
German Pointer (5.23%, 95% CI 3.93–6.80), Springer Spaniel (5.19%, 95% CI 4.76–5.66), and Labrador Retriever (5.15%,
95% CI 4.90–5.41). Dogs with an adult bodyweight equal or higher than their breed/sex mean had 1.96 (95% CI 1.81–2.14,
P < 0.001) times the odds of lipoma compared with dogs that weighed below their breed/sex mean. The odds of lipoma
increased as adult bodyweight increased. Increased age was strongly associated with increasing odds of lipoma.
Compared with dogs aged 3.0 to < 6.0 years, dogs aged 9.0 - < 12.0 years had 17.52 times the odds (95% CI 14.71–20.85,
P < 0.001) of lipoma. Neutered males (OR: 1.99, 95% CI 1.69–2.36, P < 0.001) and neutered females (OR: 1.62, 95% CI 1.37–
1.91, P < 0.001) had higher odds than entire females. Insured dogs had 1.78 (95% CI 1.53–2.07, P < 0.001) times the odds
of lipoma compared with uninsured dogs.
Conclusions: Lipomas appear to be a relatively common diagnosis in primary-care practice. Certain breeds were
identified with remarkably high lipoma prevalence, highlighting the risk that owners should be prepared for. Lipoma
predisposition of larger bodyweight individuals within breed/sex suggests that being overweight or obese may be a
predisposing factor but would need further work to confirm.
Keywords: General practice, First opinion, VetCompass, Fatty mass, Lipoma
Plain English summary
Lipomas are fatty masses that may not cause dogs sub-
stantial direct problems but can often cause severe anx-
iety to owners when there are multiple or very large
masses. These masses were the most common disorder
reported in dogs in a large UK survey of pedigree dog
owners. However, despite this, there has been very little
information published on which breeds are most
affected even though this information would be very
relevant to owners. First opinion veterinary health re-
cords are now recognised as a valuable source of infor-
mation to learn about the diseases that are diagnosed in
dogs by veterinarians. This study aimed to use the
VetCompass™ database of veterinary health records to
explore how common lipomas were in the UK and to
identify which breeds were most affected.
The study included 384,284 dogs under veterinary care
at 215 clinics in the UK during 2013. Overall, 1.94% of
the dogs were diagnosed with lipoma. The breeds that
were most commonly diagnosed were Weimaraner
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(7.84%), Dobermann Pinscher (6.96%), German Pointer
(5.23%), Springer Spaniel (5.19%), and Labrador Re-
triever (5.15%). Eleven breeds including the Yorkshire
Terrier, Lhasa Apso, German Shepherd Dog and Shih-tzu
had reduced risk of lipoma. As dogs aged, they were much
more likely to have lipoma. Neutered males and neutered
females had higher risk than entire females. Insured dogs
were almost twice as likely to be diagnosed compared with
uninsured dogs. Purebred dogs and heavier individuals
were also more likely to be diagnosed.
This large population study is the first study to focus
primarily on lipoma occurrence in the dogs in the UK.
Lipoma has been confirmed as a common diagnosis in
dogs. The strong breed associations shown for both lip-
oma predisposition and protection can assist with breed
health reforms as well as preparing owners of predis-
posed breeds for the probability of this alarming clinical
presentation.
Background
Lipomas are masses of mesenchymal origin, comprising of
adipocytes, and are often clinically unremarkable [1–3].
Individual case reports or case series have reported on
intra-cavity lipomas and lipomas adjacent to neural struc-
tures, which have caused clinical signs due to organ com-
pression [2, 4–6]. Although subcutaneous lipomas are
often clinically asymptomatic [7], they can cause deleteri-
ous consequences for the patients and anxiety for the
owners if they become sizable or interfere with locomo-
tion [1, 7, 8].
Lipomas of the dermis and subcutaneous tissues are
reported to be common in older dogs [1] and were the
most common disorder of purebred dogs in the UK in
an owner-reported survey [9]. Lipomas were the 12th
most commonly reported disorder in dogs in the south
of England with a prevalence of 3.5% reported from a
sample of 3884 dogs under primary veterinary care [10].
Fatty tumours were reported as the most common
tumour diagnosed by cytology in Dutch Golden Re-
trievers [11]. Lipomas were the most common benign
tumour (24%) identified in the Danish Cancer Registry
[12] and were the second most common tumor recorded
in insured dogs in the UK with an incidence rate of 337
per 100,000 dogs per year [13].
Despite the evidence showing relatively frequent oc-
currence in dogs, there is very little published evidence
on risk factors for lipomas. Advancing age, overweight
dogs and females have been suggested as having in-
creased risk [14]. Dobermann Pinscher and Labrador Re-
triever have also been reported as predisposed breeds
[15]. However, little other information on risk factors for
lipoma have been published.
Primary-care veterinary clinical data are now recog-
nised as a valuable research resource that benefit from
contemporaneous recording of medical records at the
time of the clinical event, and from the recording of co-
hort data over time and at a veterinary level of precision
[16, 17]. Such data have been validated for research pur-
poses by several previous reports on diverse conditions
in dogs including road traffic accidents [18], appendicu-
lar osteoarthritis [19], dystocia [20], urinary incontinence
[21] and corneal ulcerative disease [22]. This study
aimed to fill the information gap on the epidemiology of
lipoma by estimating the prevalence of lipoma, and
evaluating demographic risk factors for lipoma in the
dog population under primary-care veterinary care in
the UK. Based on the prior but scant information in the
literature, it was hypothesized that purebred dogs, older
dogs and heavier dogs would have higher odds of lipoma
than crossbred, younger and lighter dogs respectively.
Methods
The VetCompass™ Programme collates de-identified elec-
tronic patient record (EPR) data from primary-care veter-
inary practices in the UK for epidemiological research
[10]. Collaborating practices can record summary diagno-
sis terms from an embedded VeNom Code [23] list during
episodes of care. VetCompass™ collects information fields
that include species, breed, date of birth, sex, neuter sta-
tus, insurance status and bodyweight, and clinical infor-
mation from free-form text clinical notes and summary
diagnosis terms (VeNom codes), plus treatment and
deceased status with relevant dates. The EPR data were
extracted from practice management systems using inte-
grated clinical queries and uploaded to a secure VetCom-
pass™ structured query language database [24].
A cross-sectional analysis using cohort clinical data of
dogs attending VetCompass™ practices was used to esti-
mate the prevalence and risk factors for lipoma [25]. The
sampling frame for the current study included dogs under
veterinary care within the VetCompass™ database for a
one-year period from January 1st 2013 to December 31st
2013. Dogs ‘under veterinary care’ were defined as any
dog with either at least one EPR recorded from January
1st to December 31st 2013 or, alternatively, at least one
EPR both before and after 2013. Sample size calculations
estimated that a cross-sectional analysis would require a
sample size of 108,980 dogs to provide a prevalence esti-
mate for a disorder expected to occur in 1.0% of overall
population with a 0.05% confidence limit assuming a UK
population size of 8,000,000 dogs [26, 27]. Ethical approval
was granted by the RVC Ethics and Welfare Committee
(reference number 2016/U37).
Case inclusion criteria required that a final diagnosis of
lipoma (or synonym) was recorded in the EPR for a mass at
any body location that was present during the 2013 study
period. The clinical decision-making used for diagnosis of
lipoma was at the discretion of the attending veterinary
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surgeon. Case-finding involved initial screening of all EPRs
for candidate lipoma cases by searching the clinical
free-text field using search terms including lipo*, fat* +
mass*, fat* + lump*, fat* + FNA*, fat* + biop*, and the
VeNom term field using the search term lipoma. The can-
didate cases were randomly ordered by the Microsoft Excel
RAND function (Microsoft Office Excel 2007, Microsoft
Corp.) and the clinical notes of a random subset of candi-
date cases were manually reviewed in detail to evaluate for
case inclusion. All dogs that were not identified as candi-
date lipoma cases during the initial screening were included
as non-cases and all dogs that met the inclusion criteria for
lipoma were grouped as lipoma cases in the risk factor
analysis.
A purebred variable categorised all dogs of recognis-
able breeds as ‘purebred’ and the remaining dogs as
‘crossbred’ [28]. A breed variable included individual
breeds represented by over 4000 dogs in the overall
study or with ≥15 lipoma cases, a grouped category of
all remaining purebreds and a general grouping of cross-
bred dogs. This approach was taken to facilitate statis-
tical power for the individual breed analyses [29]. A
Kennel Club breed group variable classified breeds recog-
nised by the UK Kennel Club into their relevant breed
groups (Gundog, Hound, Pastoral, Terrier, Toy, Utility
and Working) and all remaining types were classified as
non-Kennel Club recognised [30]. Sex (female, male, un-
recorded) and neuter (neutered, entire, unrecorded) vari-
ables described the status recorded at the final EPR. Sex
and neuter status were also combined into a single vari-
able that reported the results across seven permutational
categories. An insurance variable described whether a
dog was insured at any point during the study period.
Age (years) was calculated for all dogs at the final date
of the study period (December 31st, 2013). An age vari-
able categorised age (years) into six groups (< 3.0, 3.0 -
< 6.0, 6.0 - < 9.0, 9.0 - < 12.0, ≥ 12.0, unrecorded). Adult
bodyweight described the maximum bodyweight (kg) re-
corded for dogs > 18 months old. An adult bodyweight
variable categorised adult bodyweight (kg) into six
groups (< 10.0, 10.0–19.9, 20.0–29.9, 30.0–39.9, ≥ 40.0,
not available). A bodyweight relative to breed mean vari-
able characterised the adult bodyweight of individual
dogs as either below or equal/above the mean adult
bodyweight for their breed and sex within the overall
study population. This variable allowed the effect of
adult bodyweight to be assessed within each breed/sex
combination.
Following data checking and cleaning in Excel (Micro-
soft Office Excel 2013, Microsoft Corp.), analyses were
conducted using Stata Version 13 (Stata Corporation).
The one-year period prevalence with 95% confidence in-
tervals (CI) described the probability of evidence in the
clinical records that confirmed the presence of lipoma at
any time during the one-year 2013 study period. Because
the sampling design involved manual verification of a
subset of the candidate cases, the predicted case count
was calculated using the Stata survey function that
weighted the verified case numbers by the inverse of the
proportion of candidate cases manually confirmed [24].
The CI estimates were derived from standard errors,
based on approximation to the normal distribution [31].
Descriptive statistics characterised the risk factors separ-
ately for the case and non-case dogs.
Binary logistic regression modelling was used to evalu-
ate univariable associations between risk factors (purebred,
breed, Kennel Club breed group, adult bodyweight, body-
weight relative to breed/sex mean, age, sex, neuter,
sex-neuter and insurance) and diagnosis of lipoma during
2013. Because breed was a factor of primary interest for
the study, purebred, and Kennel Club breed group (vari-
ables that are highly collinear with breed) and adult body-
weight (a defining characteristic of individual breeds) were
excluded from the initial breed multivariable modelling.
Instead, each of these variables individually replaced the
breed variable in the main final model in order to evaluate
their effects after taking account of the other variables.
Risk factors with liberal associations in univariable
modelling (P < 0.2) were taken forward for multivariable
evaluation. Model development used manual backwards
stepwise elimination. Clinic attended was evaluated as a
random effect and pair-wise interaction effects were evalu-
ated for the final model variables [32]. The area under the
ROC curve and the Hosmer-Lemeshow test were used to
evaluate the quality of the model fit and discrimination
(non-random effect model) [32, 33]. Statistical significance
was set at P < 0.05.
Results
The denominator population comprised 384,284 dogs
under veterinary care at 215 clinics in the UK during
2013. Of 8437 candidate cases identified, 3504 (36.5%)
were manually checked to confirm 2765 lipoma cases
from this sample. After accounting for the effects of the
subsampling protocol, the estimated one-year period
prevalence for lipoma diagnosis in dogs overall was
1.94% (95% CI: 1.87–2.01). The breeds with the highest
lipoma prevalence were Weimaraner (7.84%, 95% CI
6.46–9.40), Dobermann Pinscher (6.96%, 95% CI 5.67–
8.44), German Pointer (5.23%, 95% CI 3.93–6.80),
Springer Spaniel (5.19%, 95% CI 4.76–5.66), and Labra-
dor Retriever (5.15%, 95% CI 4.90–5.41) (Fig. 1).
Of the lipoma cases with complete data available for that
variable, 2004 (72.58%) were purebred, 1310 (47.40%) were
female, 1756 (82.21%) were neutered and 661 (72.64%)
were insured. Dogs with lipoma had a median adult body-
weight of 26.00 kg (IQR: 16.80–35.20) and median age was
10.02 years (IQR: 8.25–12.04). The most common breeds
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among the lipoma cases were Labrador Retriever (545,
19.71% of all confirmed cases), Springer Spaniel (182,
6.58%), Cocker Spaniel (130, 4.70%) and Staffordshire Bull
Terrier (116, 4.20%), along with crossbred dogs (757,
27.38%) (Table 1).
Of the non-case dogs with complete data on the vari-
able, 282,634 (75.41%) were purebred, 181,347 (48.42%)
were female, 166,332 (54.46%) were neutered and 43,293
(63.06%) were insured. The median adult bodyweight for
non-cases was 16.50 kg (IQR: 9.00–28.00) and the median
age was 4.18 years (IQR: 1.80–7.59). The most common
breeds among the non-case dogs were Labrador Retriever
(27,387, 7.29% of all non-cases), Staffordshire Bull Terrier
(25,966, 6.91%), Jack Russell Terrier (22,826, 6.07) and
Cocker Spaniel (13,099, 3.49%) accompanied by a substan-
tial population of crossbred dogs (92,149, 24.52%)
(Table 1). Data completeness varied between the variables
assessed: breed 99.7%, age 98.64%, sex 99.7%, bodyweight
at any age 88.96%, insurance 18.54%, and neuter 81.16%.
All tested variables were liberally associated with lip-
oma in univariable logistic regression modelling and
were further evaluated in the main multivariable logistic
regression modelling. The final main breed multivariable
model retained five risk factors: breed, bodyweight rela-
tive to breed mean, age, sex-neuter and insurance
(Table 2). An interaction effect was noted between sex
and neuter status so these variables were combined into
a single variable that reported the various sex-neuter
permutations results separately. No other biologically
significant interactions remained in the final model. The
final model showed good fit and discrimination (area
under the ROC curve: 0.8905, Hosmer-Lemeshow test:
P = 0.631).
After accounting for the effects of the other variables
evaluated, 8 breeds showed increased odds of lipoma com-
pared with crossbred dogs. The breeds with the highest
odds included the Dobermann Pinscher (OR: 3.55, 95% CI
2.49–5.06, P < 0.001), Weimaraner (OR: 3.16, 95% CI
2.26–4.42, P < 0.001), Labrador Retriever (OR: 2.19, 95%
CI 1.96–2.46, P < 0.001) and Springer Spaniel (OR: 2.15,
95% CI 1.82–2.54, P < 0.001). There were 11 breeds with
reduced odds of lipoma compared with crossbreds. Indi-
vidual dogs with an adult bodyweight that was equal or
higher than their breed/sex mean had 1.96 (95% CI 1.81–
2.14, P < 0.001) times the odds of lipoma compared with
dogs that weighed below their breed/sex mean. Advancing
age was strongly associated with increasing odds of lip-
oma. Compared with dogs aged 3.0 to < 6.0 years, dogs
aged 9.0 - < 12.0 years had 17.52 times the odds (95% CI
14.71–20.85, P < 0.001) of lipoma. Neutered males (OR:
1.99, 95% CI 1.69–2.36, P < 0.001) and neutered females
(OR: 1.62, 95% CI 1.37–1.91, P < 0.001) had higher odds
than entire females. Insured dogs had 1.78 (95% CI 1.53–
2.07, P < 0.001) times the odds of lipoma compared with
uninsured dogs (Table 2).
As described in the methods, 3 variables (purebred,
Kennel Club breed group and adult bodyweight) indi-
vidually replaced the breed variable in the final multivar-
iable model. Purebred dogs had 1.16 times the odds
(95% CI 1.07–1.26, P = 0.001) compared with crossbred
dogs. Of the seven Kennel Club breed groups, only Gun-
dogs (OR: 2.08, 95% CI 1.90–2.28, P < 0.001) showed
Fig. 1 One-year (2013) period prevalence of lipoma diagnosis in commonly affected dog breeds attending primary-care veterinary practices in
the VetCompass™ Programme in the UK. The error bars show the 95% confidence interval
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Table 1 Descriptive and univariable logistic regression results for risk factors associated with lipoma diagnosis in dogs attending











Purebred status Crossbred 757 (0.81) 92,149 (99.19) Base < 0.001
Purebred 2004 (0.70) 282,634 (99.30) 0.86 0.79–0.94 0.001
Breed Crossbred 757 (0.81) 92,149 (99.19) Base < 0.001
Weimaraner 39 (3.06) 1237 (96.94) 3.84 2.77–5.32 < 0.001
Dobermann Pinscher 35 (2.63) 1294 (97.37) 3.29 2.34–4.64 < 0.001
German Pointer 19 (1.97) 944 (98.03) 2.45 1.55–3.88 < 0.001
Springer Spaniel 182 (1.96) 9118 (98.04) 2.43 2.06–2.86 < 0.001
Labrador Retriever 545 (1.95) 27,387 (98.05) 2.42 2.17–2.71 < 0.001
Cairn Terrier 22 (1.74) 1243 (98.26) 2.15 1.40–3.30 < 0.001
Border Collie 112 (1.09) 10,150 (98.91) 1.34 1.10–1.64 0.004
Golden Retriever 52 (1.08) 4746 (98.92) 1.33 1.00–1.77 0.046
Beagle 29 (1.02) 2802 (98.98) 1.26 0.87–1.83 0.225
Miniature Schnauzer 33 (1.00) 3261 (99.00) 1.23 0.87–1.75 0.243
Dalmatian 15 (1.00) 1481 (99.00) 1.23 0.74–2.06 0.424
Cocker Spaniel 130 (0.98) 13,099 (99.02) 1.21 1.00–1.46 0.048
Patterdale Terrier 19 (0.90) 2087 (99.10) 1.11 0.70–1.75 0.660
Rottweiler 33 (0.75) 4340 (99.25) 0.93 0.65–1.31 0.665
Border Terrier 29 (0.61) 4724 (99.39) 0.75 0.52–1.08 0.125
Boxer 30 (0.57) 5276 (99.43) 0.69 0.48–1.00 0.049
Other purebreds 307 (0.51) 60,029 (99.49) 0.62 0.55–0.71 < 0.001
Jack Russell Terrier 107 (0.47) 22,826 (99.53) 0.57 0.47–0.70 < 0.001
Staffordshire Bull Terrier 116 (0.44) 25,966 (99.56) 0.54 0.44–0.66 < 0.001
West Highland White Terrier 41 (0.40) 10,135 (99.60) 0.49 0.36–0.67 < 0.001
Breed not recorded 4 (0.37) 1064 (99.63) 0.46 0.17–1.22 0.120
Bichon 16 (0.30) 5402 (99.70) 0.36 0.22–0.59 < 0.001
Cavalier King Charles Spaniel 21 (0.24) 8684 (99.76) 0.29 0.19–0.45 < 0.001
German Shepherd Dog 20 (0.18) 10,799 (99.82) 0.23 0.14–0.35 < 0.001
Yorkshire Terrier 21 (0.16) 12,808 (99.84) 0.20 0.13–0.31 < 0.001
Lhasa Apso 9 (0.15) 5996 (99.85) 0.18 0.09–0.35 < 0.001
Shih Tzu 15 (0.12) 12,617 (99.88) 0.14 0.09–0.24 < 0.001
Chihuahua 7 (0.07) 9755 (99.93) 0.09 0.04–0.18 < 0.001
Pug 0 (0.00) 4428 (100.00) ~ ~ ~
Kennel Club Breed Group Breed not Kennel Club recognised 906 (0.73) 123,756 (99.27) Base < 0.001
Toy 78 (0.16) 47,485 (99.84) 0.22 0.18–0.28 < 0.001
Utility 119 (0.31) 38,173 (99.69) 0.43 0.35–0.52 < 0.001
Terrier 259 (0.53) 48,432 (99.47) 0.73 0.64–0.84 < 0.001
Gundog 1016 (1.66) 60,116 (98.34) 2.31 2.11–2.53 < 0.001
Hound 86 (0.64) 13,315 (99.36) 0.88 0.71–1.10 0.268
Pastoral 173 (0.69) 25,034 (99.31) 0.94 0.80–1.11 0.489
Working 124 (0.67) 18,472 (99.33) 0.92 0.76–1.11 0.367
Adult (> 18 months) bodyweight (kg) < 10.0 200 (0.24) 83,327 (99.76) Base < 0.001
10.0–19.9 666 (0.86) 77,090 (99.14) 3.60 3.07–4.22 < 0.001
20.0–29.9 721 (1.25) 56,792 (98.75) 5.29 4.52–6.19 < 0.001
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Table 1 Descriptive and univariable logistic regression results for risk factors associated with lipoma diagnosis in dogs attending











30.0–39.9 697 (1.77) 38,609 (98.23) 7.52 6.42–8.81 < 0.001
≥ 40.0 364 (1.73) 20,657 (98.27) 7.34 6.17–8.73 < 0.001
Unrecorded 117 (0.12) 99,372 (99.88) 0.49 0.39–0.62 < 0.001
Bodyweight relative to breed mean Lower 862 (0.56) 154,194 (99.44) Base < 0.001
Equal/Higher 1787 (1.44) 122,132 (98.56) 2.62 2.41–2.84 < 0.001
Unrecorded 116 (0.12) 99,952 (99.88) 0.21 0.17–0.25 < 0.001
Age (years) < 3.0 years 24 (0.02) 142,327 (99.98) 0.11 0.07–0.18 < 0.001 < 0.001
3.0 - < 6.0 years 145 (0.15) 98,128 (99.85) Base
6.0 - < 9.0 years 797 (1.23) 64,241 (98.77) 8.40 7.03–10.02 < 0.001
9.0 - < 12.0 years 1091 (2.75) 38,600 (97.25) 19.13 16.08–22.75 < 0.001
≥ 12.0 years 697 (2.48) 27,377 (97.52) 17.23 14.40–20.62 < 0.001
Unrecorded 11 (0.21) 5174 (99.79) 1.44 0.78–2.66 < 0.001
Sex Female 1310 (0.72) 181,347 (99.28) Base < 0.001
Male 1454 (0.75) 103,177 (99.25) 1.04 0.97–1.12 0.282
Not recorded 1 (0.08) 1323 (99.92) 0.10 0.01–0.74 0.024
Neuter Entire 380 (0.27) 139,083 (99.73) Base < 0.001
Neutered 1756 (1.04) 166,332 (98.96) 3.86 3.46–4.32 < 0.001
Unrecorded 629 (0.89) 70,432 (99.11) 3.27 2.88–3.71 < 0.001
Sex-Neuter Female-entire 172 (0.26) 65,611 (99.74) Base < 0.001
Female-neutered 846 (1.01) 82,506 (98.99) 3.91 3.32–4.61 < 0.001
Female-unrecorded 292 (0.87) 33,230 (99.13) 3.35 2.78–4.05 < 0.001
Male-entire 208 (0.29) 72,573 (99.71) 1.09 0.89–1.34 0.387
Male-neutered 910 (1.08) 83,707 (98.92) 4.15 3.52–4.88 < 0.001
Male-unrecorded 336 (0.90) 36,897 (99.10) 3.47 2.89–4.18 < 0.001
Unrecorded-unrecorded 1 (0.08) 1323 (99.92) 0.29 0.04–2.06 0.215
Insurance Non-insured 249 (0.97) 25,364 (99.03) Base < 0.001
Insured 661 (1.50) 43,293 (98.50) 1.56 1.34–1.80 < 0.001
Unrecorded 1855 (0.60) 307,109 (99.40) 0.62 0.54–0.70 < 0.001
Row percentages shown in brackets. aCI confidence interval
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Table 2 Final breed multivariable logistic regression model for risk factors associated with diagnosis of lipoma in dogs attending




Breed Crossbreed 1.00 –
Dobermann Pinscher 3.55 2.49–5.06 < 0.001
Weimaraner 3.16 2.26–4.42 < 0.001
Labrador Retriever 2.19 1.96–2.46 < 0.001
Springer Spaniel 2.15 1.82–2.54 < 0.001
Beagle 2.03 1.39–2.97 < 0.001
German Pointer 2.03 1.27–3.25 0.003
Miniature Schnauzer 1.52 1.07–2.18 0.021
Cairn Terrier 1.44 0.93–2.22 0.100
Cocker Spaniel 1.26 1.04–1.53 0.016
Patterdale Terrier 1.25 0.79–1.99 0.340
Rottweiler 1.09 0.76–1.55 0.636
Border Collie 1.04 0.85–1.27 0.715
Pug 1.00 –
Dalmatian 0.95 0.56–1.59 0.842
Golden Retriever 0.83 0.63–1.10 0.209
Breed not recorded 0.72 0.27–1.97 0.525
Other purebreds 0.70 0.61–0.80 0.000
Border Terrier 0.70 0.48–1.02 0.060
Boxer 0.61 0.42–0.89 0.010
Staffordshire Bull Terrier 0.60 0.49–0.73 < 0.001
Jack Russell Terrier 0.49 0.40–0.60 < 0.001
Bichon 0.45 0.28–0.75 0.002
West Highland White Terrier 0.30 0.22–0.41 < 0.001
Cavalier King Charles Spaniel 0.29 0.18–0.44 < 0.001
Chihuahua 0.26 0.13–0.56 < 0.001
Shih-tzu 0.24 0.14–0.40 < 0.001
German Shepherd Dog 0.21 0.14–0.33 < 0.001
Lhasa Apso 0.20 0.11–0.39 < 0.001
Yorkshire Terrier 0.17 0.11–0.26 < 0.001
Bodyweight relative to breed mean Lower 1.00 –
Equal/Higher 1.97 1.81–2.14 < 0.001
Unrecorded 0.53 0.43–0.64 < 0.001
Age (years) < 3.0 years 0.18 0.12–0.28 < 0.001
3.0 - < 6.0 years 1.00 –
6.0 - < 9.0 years 7.56 6.33–9.04 < 0.001
9.0 - < 12.0 years 17.52 14.71–20.85 < 0.001
> or = 12.0 years 18.34 15.30–21.98 < 0.001
No age available 3.45 1.84–6.45 < 0.001
Sex-Neuter Female-Entire 1.00 –
Female-Neutered 1.62 1.37–1.91 < 0.001
Female-Unknown 1.41 1.16–1.72 0.001
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higher odds of lipoma compared with dogs of breeds
that are not recognized by the Kennel Club, while the
Toy, Utility, Terrier and Pastoral groups all had reduced
odds. The odds of lipoma increased as adult bodyweight
increased (Table 3).
Discussion
This is the first study to explore the wider presentation
of lipomas in dogs attending primary-care practices by
analysing clinical data from a multi-centre primary-care
research database. The previous veterinary literature on
lipomas is dominated by isolated case reports on referral
cases describing unusual clinical signs, such as coughing
due to an intra-thoracic lipoma or abnormalities related
to nerve root compression [5, 34]. Instead, the current
study explored a large count of routinely diagnosed
cases in primary-care practice by evaluating the medical
records of 384,284 dogs and identifying 2765 lipoma
cases from a random subset of 36.5% of these dogs. It
therefore, provides novel insights into the prevalence
and risk factors associated with lipomas in the general
population of dogs in the UK. A deficiency of informa-
tion on disease occurrence in the wider dog population
has previously been identified as a critical impediment
to applying an evidence-based approach to disease pri-
oritisation and breed health reforms in dogs. Analyses of
primary-care veterinary clinical data have been suggested
as a reliable source of such information [35–38].
This study based on veterinary clinical records estimated
a one-year period prevalence of 1.94% of lipoma across all
Table 2 Final breed multivariable logistic regression model for risk factors associated with diagnosis of lipoma in dogs attending




Male-Entire 0.79 0.65–0.97 0.025
Male-Neutered 1.99 1.69–2.36 < 0.001
Male-Unknown 1.43 1.18–1.74 < 0.001
Unknown-Unknown 0.82 0.11–6.04 0.844
Insurance Uninsured 1.00 –
Insured 1.78 1.53–2.07 < 0.001
Unknown 1.18 1.02–1.36 0.027
aCI confidence interval
Table 3 Results for variables that individually replaced the breed variable in the final multivariable logistic regression model (with
age, bodyweight relative to breed mean, sex-neuter and insurance status) to evaluate risk factors associated with a diagnosis of
lipoma in dogs attending primary-care veterinary practices in the VetCompass™ Programme in the UK
Variable Category Odds ratio 95% CIa Category P-value
Purebred status Crossbred Base
Purebred 1.16 1.07–1.26 0.001
Kennel Club Breed Group Breed not KC-recognised Base
Toy 0.28 0.22–0.36 < 0.001
Utility 0.57 0.47–0.69 < 0.001
Terrier 0.65 0.56–0.75 < 0.001
Gundog 2.08 1.90–2.28 < 0.001
Hound 0.86 0.69–1.08 0.187
Pastoral 0.78 0.66–0.92 0.004
Working 1.12 0.93–1.36 0.233
Adult (> 18 months) bodyweight (kg) < 10.0 Base
10.0–19.9 2.85 2.43–3.34 < 0.001
20.0–29.9 4.00 3.41–4.68 < 0.001
30.0–39.9 5.62 4.79–6.59 < 0.001
≥ 40.0 5.85 4.90–6.97 < 0.001
Unrecorded 1.14 0.90–1.44 0.265
aCI confidence interval
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dog types in the UK. This is lower than the results of an
owner questionnaire study evaluating pedigree dogs in the
UK registered with The Kennel Club (KC) that reported a
4.3% lipoma prevalence [9]. The questionnaire study asked
owners to report on conditions that they believed the dog
had at any time point and therefore reported a
current-lifetime prevalence which would anticipate higher
values than the current study which reported a one-year
period prevalence. The questionnaire study also relied on
owners recall of previous conditions and included condi-
tions that the owners ‘diagnosed’ themselves without
necessarily including veterinary input so the results may
have been influenced by some misclassification and recall
bias effects [32]. However, the results did single out lipoma
as the most common owner-recalled disorder in pedigree
dogs and suggests that owners are highly conscious of lip-
oma masses and retain recall for their occurrence over long
periods. In consequence, however benign that lipomas may
behave clinically, it is likely that owners find these masses
as highly noteworthy and even alarming, and therefore
veterinarians should be especially explicit in their explana-
tions of the clinical significance of these masses to clients.
The current study investigated the general dog popula-
tion under veterinary care, which included pedigreed
and non-pedigreed purebreds as well as designer-types
and unspecified crossbreed dogs. Our study reported a
1.16 times higher odds of lipoma in purebred dogs com-
pared with crossbred dogs which may further explain
the higher prevalence in the KC-registered pedigree dogs
of the questionnaire study. It should be noted that the
one-year period prevalence reported in the current paper
described the probability of evidence in the clinical re-
cords that confirmed the presence of lipoma at any time
during the one-year 2013 study period. This value in-
cludes both cases that were pre-existing to 2013 as well
as cases that were newly diagnosed (i.e. incident) during
2013. Consequently, period prevalence values are gener-
ally higher than incident risks for the same period and
these are therefore not directly comparable metrics [32].
It should also be noted that there may have been animals
with lipoma in the underlying population that were not re-
corded with the condition in the clinical notes (e.g. the
dog was not presented for veterinary care during 2013 or
the diagnosis was missed by the attending veterinary sur-
geon) and therefore the true one-year period prevalence
of lipoma may be higher than the value reported here.
The current study had a particular interest in breed risk
factors for lipoma. At this point, it is worth noting an infer-
ential distinction between breeds that comprise a high pro-
portion of lipoma caseloads in a clinical setting (i.e.
influenced by being both/or a proportionately common
breed and a proportionately commonly-affected breed) and
breeds that are predisposed to lipoma (influenced by being
a proportionately commonly-affected breed). Common
presentation in veterinary clinics with a specific condition
can reflect varying relative contributions from the overall
popularity of the breed, confounding factors (e.g. insurance
status, age structure of the breed in the local underlying pet
population) as well as innate breed predisposition. For ex-
ample, Labrador Retrievers are the most common dog breed
in the UK and therefore would be expected to comprise a
greater proportion of clinical caseloads than a less common
breed such as the Weimaraner for disorders where these
two breeds shared the same level of innate predisposition
[10]. This distinction underlies the cognitive bias, which
could be called a “presentation bias”, whereby common
breeds are often perceived as predisposed just because they
are commonly observed with certain disorders in clinical
practice [39]. The current study shows a nice example of
this presentation bias effect; the Labrador Retriever was the
most commonly presented breed (19.71% of all cases) com-
pared with the Weimaraner that had fewer than one-tenth
of this case count (1.41% of all cases). However, the
Weimaraner had a higher within-breed prevalence (7.84%)
than the Labrador Retriever (5.15%) (Fig. 1). After taking
other associated confounding factors into account such as
relative bodyweight, age, sex-neuter and insurance, the Wei-
maraner still had higher odds of lipoma than the Labrador
Retriever (OR: 3.16 vs. 2.19) (Table 2). These results empha-
sise the value of a thorough epidemiological analysis to get a
truer understanding of breed health and highlight the risks
of cognitive biases in personal perception [40].
A genetic hereditary component to developing lipomas
overall has previously been suggested [41]. Certain dog
breeds such as Labrador Retriever and Dobermann Pincher
are regularly cited with higher risk of lipoma but following
the literature back to the original source studies identifies
that these claims are based on very weak evidence [42–44].
In contrast, the current study provides strong evidence of
breed predilections for lipoma. After accounting for other
confounding factors, there were 8 breeds that showed
predisposition compared with crossbreds: Dobermann
Pinscher, Weimaraner, Labrador Retriever, Springer Span-
iel, Beagle, German Pointer, Miniature Schnauzer and
Cocker Spaniel. It is also noteworthy that 5 of the 8 predis-
posed breeds are classified in the Kennel Club Gundog
Group: Weimaraner, Labrador Retriever, Springer Spaniel,
German Pointer, and Cocker Spaniel. Indeed, the Gundog
Group was the only Kennel Club group with increased
odds of lipoma, showing 2.08 times the odds compared
with dogs that were not breed-recognised by the Kennel
Club. The Gundog Group is divided into four categories
(Retrievers; Spaniels; Hunt/Point/Retrieve; Pointers/Set-
ters) and includes dogs that were originally trained to find
live game and/or to retrieve game that had been shot and
wounded [45]. Such breeds may have been selected to
work in wintry adverse weather conditions, spending ex-
tended periods stationary to avoid scaring the game whilst
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also retaining high athletic ability on sudden request. It is
possible that these dual working demands selected for spe-
cific adipose characteristics; for example, with differing
propositions of isoforms of adipose uncoupling proteins or
ratio of brown to white fat [46–48]. The Kennel Club de-
scribes the Gundog Group as good companion animals
with temperaments ideal as all-round family dogs, suggest-
ing that the majority of current generations of Gundogs
are non-working but are instead owned as family pets [45].
It may be that the original adipose selection processes as
working animals combined with the more sedentary and
highly nourished life of the modern pet dog combine to ex-
pose an increased tendency to lipoma. It is also noteworthy
that many of the predisposed breeds share a similar body
conformation: medium–to-large bodysize, barrel chest and
tapered abdomen and a smooth hair coat [30]. These fea-
tures may facilitate identification of subcutaneous masses
meaning that lipomas at these locations are easier to recog-
nise in these breeds and therefore contribute to recognition
bias in these breeds.
To date in the veterinary literature, the majority of
breed-focussed disease studies have reported only positive
predisposition to disease. This approach supports the iden-
tification of breeds with increased risk of disease that may
undergo breed health reforms to try to breed away from
some risk attributes [35]. It is also worth considering set-
ting an alternative research goal that instead identifies
breeds that are negatively predisposed to disease (i.e. pro-
tected). Greater understanding of why certain breeds or
dog types do not get disease may offer as much, if not
more, welfare progress than tunnel-vision focus on the pre-
dilected breeds [15]. The current study embraced this sec-
ond approach and identified 11 breeds with lower lipoma
odds than crossbreds: Yorkshire Terrier, Lhasa Apso, Ger-
man Shepherd Dog, Shih-tzu, Chihuahua, Cavalier King
Charles Spaniel, West Highland White Terrier, Bichon,
Jack Russell Terrier, Staffordshire Bull Terrier and Boxer.
These protected breeds do not include a single Gundog
Group breed and have noticeably different body conform-
ation to the predisposed breeds, tending to be smaller in
bodysize and to have less pronounced proportional differ-
ence between the thorax and abdomen. Further research
the genetics of adipose, and differential fat function and ac-
cumulation across the predisposed and protected dog
breeds identified in the current study is warranted and
may lead to substantial new discovery of lipoma pathogen-
etic pathways.
The current study explored associations between body-
size and lipoma. Body condition score data were not avail-
able so no conclusive inference can be drawn from these
results on associations between obesity and lipoma. How-
ever, data were available that characterised the adult body-
weight of individual dogs as either below or equal/above
the mean adult bodyweight for their breed and sex within
the overall study population. This variable allowed the ef-
fect of low versus high adult bodyweight to be assessed
after taking into account breed and sex. Among other rea-
sons, a high bodyweight could reflect enhanced muscular
mass, a large body frame or overweight/obesity. Dogs
weighing at or above the mean for their breed and sex had
1.97 times the odds of diagnosis with lipoma. This sup-
ports the study hypothesis and suggests value in future ex-
ploration of lipoma association with obesity/overweight
since the latter is a modifiable risk factor. This approach is
also supported by published evidence of predisposition to
obesity in some of the breeds that were also identified
with high odds of lipoma in the current study including
Cocker Spaniel [49] and Labrador Retrievers [50].
This study also identified a substantial and strong trend
towards increasing odds of lipoma as adult bodyweight in-
creased. This may reflect a true increase in odds of cellular
metaplasia or neoplasia with increasing bodyweight.
Osteosarcoma in dogs has similarly been linked to in-
creasing bodyweight, although the biological mechanisms
may be different for the different neoplasms [41].
Advancing age has previously been identified as a risk
factor for neoplasia in general [41, 51]. Specifically,
adenocarcinoma/adenoma, melanocytic tumour and
squamous cell carcinoma diagnosis increased with age in
a large study using the Swiss Canine Cancer Registry
[51] and osteosarcoma risk increased with age in Grey-
hounds in the US [52]. It is possible that the same is true
for risk of lipoma development. The current study re-
ports the median age of lipomas cases was 10.02 years
compared with the median age of 4.18 years for
non-lipoma dogs. The odds of lipoma also increased
markedly as dogs aged, with dogs aged 9–12 years hav-
ing 17.52 times the odds compared with dogs aged less
than 3 years. There is a strong case to be made that lip-
oma should be included as one of the accepted common
diseases of aging in dogs [53]. Risk factors for lipoma de-
velopment in people are reported to be similar to the
findings of our study in dogs although there is also a
paucity of literature on the occurrence of lipomas in
people. In humans, the incidence of lipomas is increased
in patients with obesity, hyperlipidemia, and diabetes
mellitus [54]. A genetic component is suspected for lip-
oma development in people [55]. A genetic link has not
been reported in dogs but the breed predisposition found
in this study suggests that a genetic component to the risk
of developing lipomas is also likely to exist in dogs.
The influences of sex hormones on tumour develop-
ment is complex; neuter status has been reported with
differing effects on different tumour types and to influ-
ence the risk of developing both genital and non-genital
neoplasia [56]. For example non-ovariectomised bitches
have been reported at increased risk of developing mam-
mary carcinoma and castrated male dogs at increased
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risk of prostatic carcinoma [12, 13, 56–60]. However,
Rottweilers undergoing early gonadectomy (before
12 months of age) were reported at increased risk of
osteosarcoma [56, 61, 62]. There is little prior evidence
on the effects of sex and neuter status on the risk of lip-
oma. The current study identified reduced risk of lipoma
in entire females and entire males compared with neutered
females and neutered males, even after taking age into ac-
count. This could indicate some protective effects of female
and male sex hormones. However, post-neutering changes
in fat distribution and decreased energy requirements have
been demonstrated and the effects of neutering on lipoma
risk may be mediated by obesity as a confounder rather
than directly [63].
Insured dogs had 1.78 times greater odds of lipoma
diagnosis compared with uninsured dogs. This association
is likely to reflect increased diagnostic recognition medi-
ated by owner and financial factors rather than any intrin-
sic increased disease risk in insured dogs. Relaxation on
financial constraints to presentation for veterinary care,
diagnostic procedures and surgical management through
insurance has similarly been shown to increase diagnostic
probability in many other conditions [64–69].
Limitations
This study was limited by its retrospective nature and the
use of externally recorded clinical data; which may have
led to some disease status misclassification. This study
may have underrepresented lipoma because true cases
that were not presented for veterinary care during 2013
were not included as cases. Alternatively, lipoma could be
over-represented because the study did not require labora-
tory confirmation of lipoma cases; although the character-
istic presenting phenotype of lipoma cases suggests that
diagnosis based on clinical examination alone is likely to
have a high positive predictive value [70]. This study ex-
cluded dogs that were not under veterinary care and
therefore may have introduced bias toward the increas-
ingly neutered, insured and more closely monitored subset
of the population under veterinary care. As discussed
above, body condition scores were not available for this
study and therefore analysis of association between obesity
and lipoma was not possible. The analyses did not take
account of effects from differing counts or location of
lipoma masses across the population and it is possible that
these features also vary across breeds and other demo-
graphic risk factors.
Conclusions
This large population study is the first study to focus pri-
marily on lipoma occurrence in the dogs in the UK. Lipoma
has been confirmed as a common clinical occurrence with
a one-year prevalence of 1.94%. Strong breed associations
for both lipoma predisposition and protection were identi-
fied that can assist with breed health reforms as well as
contributing to the basic scientific understanding of lipoma
development. Heavier, older, neutered and insured dogs
also had higher odds of diagnosis. Lipoma detection should
be included as a routine part of veterinary clinical exanima-
tion, especially in breeds identified as high-risk here.
Abbreviations
CI: Confidence interval; EPR: Electronic patient record; FNA: Fine needle
aspiration; IQR: Interquartile range; KC: The Kennel Club; OR: Odds ratio
Acknowledgements
Thanks to Noel Kennedy (RVC) for VetCompass™ software and programming
development. We acknowledge the Medivet Veterinary Partnership, Vets4Pets/
Companion Care, Blythwood Vets, Vets Now and the other UK practices who
collaborate in VetCompass™. We are grateful to The Kennel Club, The Kennel
Club Charitable Trust and Dogs Trust for supporting VetCompass™.
Funding
DON was supported at the RVC for part of this study by an award from the
Kennel Club Charitable Trust. Neither the Kennel Club Charitable Trust nor the
Kennel Club had any input in the design of the study, the collection, analysis
and interpretation of data or in writing the manuscript should be declared.
Availability of data and materials
The datasets generated and analysed during the current study are not
publicly available due to their use in ongoing primary research but
subsections may be made available from the corresponding author on
reasonable request.
Authors’ contributions
DON, CC and LR were responsible mainly for the conception and design,
acquisition and extraction of data. DON carried out the analysis. DON, CC, LR,
DB and DC were involved in interpretation of the results, drafting and
revising the manuscript and gave final approval of the version to be
published. DON, CC, LR, DB and DC agree to be accountable for all aspects
of the accuracy or integrity of the work.
Ethics approval and consent to participate





The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Production and Population Health, The Royal Veterinary College, Hawkshead
Lane, North Mymms, Hatfield, Herts AL9 7TA, UK. 2Clinical Sciences and
Services, The Royal Veterinary College, Hawkshead Lane, North Mymms,
Hatfield, Herts AL9 7TA, UK.
Received: 2 July 2018 Accepted: 10 September 2018
References
1. Van Nimwegen S, Kirpensteijn J. Specific disorders. In: Tobias KM, Johnston
SA, editors. Veterinary surgery : small animal. 1st ed. St. Louis: Elsevier
Saunders; 2017.
2. Spoldi E, Schwarz T, Sabattini S, Vignoli M, Cancedda S, Rossi F.
Comparisons among computed tomographic features of adipose masses in
dogs and cats. Vet Radiol Ultrasound. 2017;58(1):29–37.
O’Neill et al. Canine Genetics and Epidemiology  (2018) 5:9 Page 11 of 13
3. Meuten DJ. In: Meuten DJ, editor. Tumors in domestic animals. 4th ed.
Ames: Iowa State University Press; 2002.
4. Avallone G, Roccabianca P, Crippa L, Lepri E, Brunetti B, Bernardini C, et al.
Histological classification and Immunohistochemical evaluation of MDM2
and CDK4 expression in canine Liposarcoma. Vet Pathol. 2016;53(4):773–80.
5. Lynch S, Halfacree Z, Desmas I, Cahalan SD, Keenihan EK, Lamb CR.
Pulmonary lipoma in a dog. J Small Anim Pract. 2013;54(10):555–8.
6. Kraun MB, Nelson NC, Hollinger C. Imaging diagnosis—computed
tomographic, surgical, and histopathologic characteristics of an infiltrative
angiolipoma in a dog. Vet Radiol Ultrasound. 2015;56(3):E31–E5.
7. Liptak J, Forrest L. Soft Tissue Sarcomas. In: Withrow S, Vail D, Page R,
editors. Small Animal Clinical Oncology. 5th ed. St Louis: Elsevier Saunders;
2013. p. 356–80.
8. Thomson MJ, Withrow SJ, Dernell WS, Powers BE. Intermuscular lipomas of the
thigh region in dogs: 11 cases. J Am Anim Hosp Assoc. 1999;35(2):165–7.
9. Wiles BM, Llewellyn-Zaidi AM, Evans KM, O'Neill DG, Lewis TW. Large-scale
survey to estimate the prevalence of disorders for 192 kennel Club
registered breeds. Canine Genet Epidemiol. 2017;4(1):8.
10. O'Neill DG, Church DB, McGreevy PD, Thomson PC, Brodbelt DC. Prevalence
of disorders recorded in dogs attending primary-care veterinary practices in
England. PLoS One. 2014;9(3):1–16.
11. Boerkamp K, Teske E, Boon L, Grinwis G, van den Bossche L, Rutteman G.
Estimated incidence rate and distribution of tumours in 4,653 cases of
archival submissions derived from the Dutch golden retriever population.
BMC Vet Res. 2014;10(1):34.
12. Brønden LB, Nielsen SS, Toft N, Kristensen AT. Data from the Danish
veterinary Cancer registry on the occurrence and distribution of neoplasms
in dogs in Denmark. Vet Rec. 2010;166(19):586–90.
13. Dobson JM, Samuel S, Milstein H, Rogers K, Wood JLN. Canine neoplasia in
the UK: estimates of incidence rates from a population of insured dogs. J
Small Anim Pract. 2002;43(6):240–6.
14. Hendrick M. Mesenchymal Tumours of the skin and soft tissues. In: Meuten
DJ, editor. Tumors in domestic animals. 5th ed. Ames: John Wiley and Sons;
2017. p. 142–75.
15. Gough A, Thomas A, O'Neill D. Breed predispositions to disease in dogs and
cats. 3rd ed. Chichester: Wiley-Blackwell; 2018. p. 398.
16. O'Neill D, Church D, McGreevy P, Thomson P, Brodbelt D. Approaches to
canine health surveillance. Canine Genet Epidemiol. 2014;1(1):2.
17. McGreevy PD, Nicholas FW. Some practical solutions to welfare problems in
dog breeding. Anim Welf. 1999;8:329–41.
18. Harris GL, Brodbelt D, Church D, Humm K, McGreevy PD, Thomson PC, et al.
Epidemiology, clinical management, and outcomes of dogs involved in
road traffic accidents in the United Kingdom (2009–2014). J Vet Emerg Crit
Care. 2018,28(2):140-8.
19. Anderson KL, O'Neill DG, Brodbelt DC, Church DB, Meeson RL, Sargan D, et
al. Prevalence, duration and risk factors for appendicular osteoarthritis in a
UK dog population under primary veterinary care. Sci Rep. 2018;8(1):5641.
20. O'Neill DG, O'Sullivan AM, Manson EA, Church DB, Boag AK, McGreevy PD,
et al. Canine dystocia in 50 UK first-opinion emergency-care veterinary
practices: prevalence and risk factors. Vet Rec. 2017;181(4).
21. O'Neill DG, Riddell A, Church DB, Owen L, Brodbelt DC, Hall JL. Urinary
incontinence in bitches under primary veterinary care in England:
prevalence and risk factors. J Small Anim Pract. 2017;58(12):685–93.
22. O'Neill DG, Lee MM, Brodbelt DC, Church DB, Sanchez RF. Corneal ulcerative
disease in dogs under primary veterinary care in England: epidemiology
and clinical management. Canine Genet Epidemiol. 2017;4(1):5.
23. The VeNom Coding Group: VeNom Veterinary Nomenclature [http://www.
venomcoding.org]. Accessed 13 Sept 2018.
24. O'Neill DG, Scudder C, Faire JM, Church DB, McGreevy PD, Thomson PC, et
al. Epidemiology of hyperadrenocorticism among 210,824 dogs attending
primary-care veterinary practices in the UK from 2009 to 2014. J Small Anim
Pract. 2016;57(7):365–73.
25. Pearce N. Classification of epidemiological study designs. Int J Epidemiol.
2012;41(2):393–7.
26. Epi Info 7 CDC: Centers for Disease Control and Prevention (US): Introducing
Epi Info 7 [http://wwwn.cdc.gov/epiinfo/7]. Accessed 13 Sept 2018.
27. Murray JK, Browne WJ, Roberts MA, Whitmarsh A, Gruffydd-Jones TJ. Number
and ownership profiles of cats and dogs in the UK. Vet Rec. 2010;166(6):163–8.
28. Irion DN, Schaffer AL, Famula TR, Eggleston ML, Hughes SS, Pedersen NC.
Analysis of genetic variation in 28 dog breed populations with 100
microsatellite markers. J Hered. 2003;94(1):81–7.
29. Scott M, Flaherty D, Currall J. Statistics: how many? J Small Anim Pract. 2012;
53(7):372–6.
30. The Kennel Club: Breed Information Centre [http://www.thekennelclub.org.
uk/services/public/breed/]. Accessed 13 Sept 2018.
31. Kirkwood BR, Sterne JAC. Essential medical statistics. 2nd ed. Oxford:
Blackwell Science; 2003.
32. Dohoo I, Martin W, Stryhn H. Veterinary epidemiologic research. 2nd ed. VER
Inc: Charlottetown; 2009.
33. Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed.
Hoboken: Wiley; 2013.
34. Wahle AM, Raith K, Posch B, Eddicks L, Matiasek K, Jurina K. Imaging
diagnosis - concentric periradicular lipoma causing lumbar nerve root
compression in a dog. Vet Radiol Ultrasound. 2016;58(1):E6–E10.
35. Bateson P. Independent inquiry into dog breeding. Cambridge: University of
Cambridge; 2010.
36. Rooney NJ. The welfare of pedigree dogs: cause for concern. J Vet Behav.
2009;4(5):180–6.
37. McGreevy PD. Breeding for quality of life. Anim Welf. 2007;16:125–8.
38. Collins LM, Asher L, Summers JF, Diesel G, McGreevy PD. Welfare
epidemiology as a tool to assess the welfare impact of inherited defects on
the pedigree dog population. Anim Welf. 2010;19:67–75.
39. Pines JM. Profiles in patient safety: confirmation Bias in emergency
medicine. Acad Emerg Med. 2008;13(1):90–4.
40. Croskerry P. The importance of cognitive errors in diagnosis and strategies
to minimize them. Acad Med. 2003;78(8):775–80.
41. Dobson JM. Breed-predispositions to cancer in pedigree dogs. ISRN Vet Sci.
2013. (Article ID 941275):1–23.
42. Kim H-J, Chang H-S, Choi C-B, Song Y-S, Kim S-M, Lee J-S, et al. Infiltrative
lipoma in cervical bones in a dog. J Vet Med Sci. 2005;67(10):1043–6.
43. Hobert MK, Brauer C, Dziallas P, Gerhauser I, Algermissen D, Tipold A, et al.
Infiltrative lipoma compressing the spinal cord in 2 large-breed dogs. Can
Vet J. 2013;54(1):74–8.
44. Bergman PJ, Withrow SJ, Straw RC, Powers BE. Infiltrative lipoma in dogs: 16
cases (1981-1992). J Am Vet Med Assoc. 1994;205(2):322–4.
45. The Kennel Club: Breed Standards Information: Dog Breeds & Groups [https://
www.thekennelclub.org.uk/activities/dog-showing/breed-standards/]. Accessed
13 Sept 2018.
46. Jimenez AG. Physiological underpinnings in life-history trade-offs in man’s most
popular selection experiment: the dog. J Comp Physiol B. 2016;186(7):813–27.
47. McKenzie EC, Hinchcliff KW, Valberg SJ, Williamson KK, Payton ME, Davis MS.
Assessment of alterations in triglyceride and glycogen concentrations in
muscle tissue of Alaskan sled dogs during repetitive prolonged exercise.
Am J Vet Res. 2008;69(8):1097–103.
48. Kajimura S, Seale P, Tomaru T, Erdjument-Bromage H, Cooper MP, Ruas JL,
et al. Regulation of the brown and white fat gene programs through a
PRDM16/CtBP transcriptional complex. Genes Dev. 2008;22(10):1397–409.
49. Lund EM, Armstrong PJ, Kirk CA, Klausner JS. Prevalence and risk factors for
obesity in adult dogs from private US veterinary practices. Int J Appl Res Vet
Med. 2006;4(2):177–86.
50. Mankowska M, Krzeminska P, Graczyk M, Switonski M. Confirmation that a
deletion in the POMC gene is associated with body weight of Labrador
retriever dogs. Res Vet Sci. 2017;112:116–8.
51. Grüntzig K, Graf R, Boo G, Guscetti F, Hässig M, Axhausen KW, et al. Swiss
canine Cancer registry 1955–2008: occurrence of the most common tumour
diagnoses and influence of age, breed, body size, sex and neutering status
on tumour development. J Comp Pathol. 2016;155:156–70.
52. Rosenberger JA, Pablo NV, Crawford PC. Prevalence of and intrinsic risk
factors for appendicular osteosarcoma in dogs: 179 cases (1996-2005). J Am
Vet Med Assoc. 2007;231(7):1076–80.
53. Creevy KE, Austad SN, Hoffman JM, O'Neill DG, Promislow DEL: The
Companion Dog as a Model for the Longevity Dividend. In: Olshansky SJ,
Kirkland JL, Martin GM, editors. Aging: The Longevity Dividend. 6. Cold
Spring Harbor: Cold Spring Harbor Laboratory Press; 2016. p. 107-20.
54. Bird JE, Morse LJ, Feng L, Wang W-L, Lin PP, Moon BS, et al. Non-
radiographic risk factors differentiating atypical Lipomatous tumors from
lipomas. Front Oncol. 2016;6(197):1-6.
55. Kolb L, Rosario-Collazo JA. Lipoma. Treasure Island (FL): StatPearls; 2018.
56. Smith AN. The role of neutering in Cancer development. Vet Clin. 2014;44(5):965–75.
57. Egenvall A, Bonnett BN, Öhagen P, Olson P, Hedhammar Å, von Euler H. Incidence
of and survival after mammary tumors in a population of over 80,000 insured
female dogs in Sweden from 1995 to 2002. Prev Vet Med. 2005;69(1–2):109–27.
O’Neill et al. Canine Genetics and Epidemiology  (2018) 5:9 Page 12 of 13
58. Merlo DF, Rossi L, Pellegrino C, Ceppi M, Cardellino U, Capurro C, et al.
Cancer incidence in pet dogs: findings of the animal tumor registry of
Genoa, Italy. J Vet Intern Med. 2008;22(4):976–84.
59. Teske E, Naan EC, van Dijk EM, Van Garderen E, Schalken JA: Canine prostate
carcinoma: epidemiological evidence of an increased risk in castrated dogs.
Mol Cell Endocrinol 2002,197(1–2):251–255.
60. Bryan JN, Keeler MR, Henry CJ, Bryan ME, Hahn AW, Caldwell CW. A
population study of neutering status as a risk factor for canine prostate
cancer. Prostate. 2007;67(11):1174–81.
61. Cooley DM, Beranek BC, Schlittler DL, Glickman NW, Glickman LT, Waters DJ.
Endogenous gonadal hormone exposure and bone sarcoma risk. Cancer
Epidemiol Biomarkers Prev. 2002;11(11):1434.
62. de la Riva GT, Hart BL, Farver TB, Oberbauer AM, Messam LLM, Willits N, et
al. Neutering dogs: effects on joint disorders and cancers in Golden
retrievers. PLoS One. 2013;8(2):e55937.
63. Jeusette I, Detilleux J, Cuvelier C, Istasse L, Diez M. Ad libitum feeding
following ovariectomy in female beagle dogs: effect on maintenance
energy requirement and on blood metabolites. J Anim Physiol Anim Nutr
(Berl). 2004;88(3–4):117–21.
64. O'Neill DG, Elliott J, Church DB, McGreevy PD, Thomson PC, Brodbelt DC.
Chronic kidney disease in dogs in UK veterinary practices: prevalence, risk
factors, and survival. J Vet Intern Med.2013;27(4):814-21.
65. O'Neill DG, Meeson RL, Sheridan A, Church DB, Brodbelt DC. The
epidemiology of patellar luxation in dogs attending primary-care veterinary
practices in England. Canine Genet Epidemiol. 2016;3:4.
66. Shoop SJ, Marlow S, Church DB, English K, McGreevy PD, Stell AJ, et al.
Prevalence and risk factors for mast cell tumours in dogs in England. Canine
Genet Epidemiol. 2015;2(1).
67. Mattin M, O'Neill D, Church D, McGreevy PD, Thomson PC, Brodbelt D. An
epidemiological study of diabetes mellitus in dogs attending first opinion
practice in the UK. Vet Rec. 2014;174(14):349.
68. Mattin MJ, Boswood A, Church DB, López-Alvarez J, McGreevy PD, O'Neill
DG, et al. Prevalence of and risk factors for degenerative mitral valve disease
in dogs attending primary-care veterinary practices in England. J Vet Intern
Med. 2015;29(3):847–54.
69. Taylor-Brown FE, Meeson RL, Brodbelt DC, Church DB, McGreevy PD,
Thomson PC, et al. Epidemiology of cranial cruciate ligament disease
diagnosis in dogs attending primary-care veterinary practices in England.
Vet Surg. 2015;44(6):777–83.
70. Bacon N. Soft tissue sarcomas. In: Dobson J, BDX L, editors. BSAVA manual
of canine and feline oncology. 3rd ed. Quedgeley: British Small Animal
Veterinary Association; 2011. p. 178–90.
O’Neill et al. Canine Genetics and Epidemiology  (2018) 5:9 Page 13 of 13
